Antibody, Gene Therapy and Genome Project - Clinical Research Informer

Can genetic data be a magic bullet for drug R&D?

pharmaphorum

JANUARY 24, 2023

Pharma has used this to begin creating targeted treatments, such as gene therapies , which are able to hone in on gene mutations that cause health issues and eradicate or replace the faulty gene. The information gathered from the project is still providing insights today, a decade later.

Genetics

Genetics Drugs Genome Project Biobanking

The Biotech Effect

Pharmaceutical Technology

AUGUST 26, 2008

. “The inherent advantages of biopharma are that it allows you to pursue therapies against targets that are not small molecule therapies, for example by targeting protein-protein interactions and targeting GPCRs (G-protein coupled receptors),” he says. “Biotechnology has exploded across the industry.

Antibody

Antibody Licensing Licensing Production

Clinical Research Informer

Can genetic data be a magic bullet for drug R&D?

The Biotech Effect

Webinars

Stay Connected